A higher-than-expected prevalence of gene mutations in Parkinson's disease patients suggests genetic testing should be offered to them more broadly, researchers said on July 29 in the medical journal Brain.

Genetic profiling performed in more than 8,000 patients of varying races and ethnicities, all with Parkinson's disease, showed 13 per cent had a genetic form of the progressive brain disorder, the researchers found.

That rate was 18 per cent in patients with known risk factors, such as an earlier age at onset, Parkinson's disease in a first-degree relative, or certain ancestry such as Ashkenazi Jewish, Spanish Basque or North African Berber.

Among patients with no known risk factors, more than nine per cent had a predisposing genetic mutation.

With new gene-specific drugs for the disease entering the research pipeline, the implications of the findings are significant, the researchers said.

Previous studies had suggested that about five per cent to 10 per cent of Parkinson's disease cases were linked with genetic variants — and most of those studies had been limited to patients with known risk factors.

Related

---